Russian Researchers Present Potentially Game-Changing Cancer Drug

A leading Russian innovative biotech company BIOCAD presented a breakthrough cancer drug and early test reports suggesting it is more effective in battling the disease than anything else on the market. The new drug has been prepared for clinical tests, with cancer patients from all over the world set to take part. According to researchers from the Saint Petersburg based company, Russia could be the first to have access to the breakthrough therapy with treatment becoming available in 2018-2019.